Understanding the anti-tumour immune response to radionuclide therapy using PSMA targeting radiopharmaceuticals in a prostate cancer model
<p>The ability of external beam radiation (EBRT) to modulate the tumour immune microenvironment is becoming increasingly well understood, leading to the development of combinatorial EBRT and immunotherapeutic combinations to improve patient responses. Despite this, there is very limited unders...
Үндсэн зохиолч: | Anderson, R |
---|---|
Бусад зохиолчид: | Vallis, K |
Формат: | Дипломын ажил |
Хэл сонгох: | English |
Хэвлэсэн: |
2021
|
Нөхцлүүд: |
Ижил төстэй зүйлс
-
Recent Progress of Functionalized PSMA in Radionuclide Targeted Therapy for Prostate Cancer
-н: REN Ya'nan, зэрэг
Хэвлэсэн: (2020-12-01) -
Lead-212 Radiopharmaceuticals for Receptor-Targeted Radionuclide Therapy
-н: Solmaz Mojarad-Jabali, зэрэг
Хэвлэсэн: (2025-01-01) -
Radiopharmaceuticals: From Molecular Imaging to Targeted Radionuclide Therapy
-н: P. August Schubiger, зэрэг
Хэвлэсэн: (2004-10-01) -
Precision strikes: PSMA-targeted radionuclide therapy in prostate cancer – a narrative review
-н: Paweł Szponar, зэрэг
Хэвлэсэн: (2023-11-01) -
Can PSMA-Targeting Radiopharmaceuticals Be Useful for Detecting Hepatocellular Carcinoma Using Positron Emission Tomography? An Updated Systematic Review and Meta-Analysis
-н: Alessio Rizzo, зэрэг
Хэвлэсэн: (2022-11-01)